2014 Advances in Cancer Immunotherapy™ - Portland, OROctober 3, 2014Earle A. Chiles Research Institute, Providence Cancer CenterPortland, ORProgram SummaryFrom the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI)- Portland program enduring materials are provided here.Upon completion of this program, the participants will be able to:
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session I: Basic Principles of Tumor Immunology and Immunotherapy; Presentation: Immunology 101; Presenter: Amy E Moran, PhD - Earle A. Chiles Research Institute, Providence Cancer Center; Date: October 3, 201400:52:40
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session II: Checkpoint Blockade-Based Immunotherapy; Presentation: CTLA-4 Blockade: Indications and Clinical Management; Presenter: Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center; Date: October 3, 201400:33:50
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session I: Basic Principles of Tumor Immunology and Immunotherapy; Presentation: Principles of Immunotherapy; Presenter: Bernard A. Fox, PhD - Earle A. Chiles Research Institute, Providence Cancer Center; Date: October 3, 201400:29:13
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session II: Checkpoint Blockade-Based Immunotherapy; Presentation: Blockade of the PD-1/PD-L1 Axis Inhibition; Presenter: Omid Hamid, MD - The Angeles Clinic and Research Institute, Providence Cancer Center; Date: October 3, 201400:29:58
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session II: Checkpoint Blockade-Based Immunotherapy; Presentation: Combinations and Other Immune Checkpoint Inhibitors/Agonists; Presenter: Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center, Providence Cancer Center; Date: October 3, 201400:27:59
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session III: Non-Checkpoint Blockade-Based Immunotherapy; Presentation: Adoptive T Cell Therapy with Variations; Presenter: Mark Faries, MD - The John Wayne Cancer Institute; Date: October 3, 201400:29:00
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session I: Basic Principles of Tumor Immunology and Immunotherapy; Presentation: Regulation of the Immune Response; Presenter: Michael J. Gough, PhD - Earle A. Chiles Research Institute, Providence Cancer Center; Date: October 3, 201400:25:47
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session III: Non-Checkpoint Blockade-Based Immunotherapy; Presentation: Cytokines (IL-2 and IFN): Indication and Clinical Management; Presenter: Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center, Providence Cancer Center; Date: October 3, 201400:25:18
Meeting: Advances in Cancer Immunotherapy™- Portland, OR; Session II: Checkpoint Blockade-Based Immunotherapy; Presentation: Radiation and Immunotherapy; Presenter: Marka R. Crittenden, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center, Providence Cancer Center; Date: October 3, 201400:22:12